Cargando…
Combining PARP Inhibition, Radiation, and Immunotherapy: A Possible Strategy to Improve the Treatment of Cancer?
Immunotherapy has revolutionized the practice of oncology, improving survival in certain groups of patients with cancer. Immunotherapy can synergize with radiation therapy, increase locoregional control, and have abscopal effects. Combining it with other treatments, such as targeted therapies, is a...
Autores principales: | Césaire, Mathieu, Thariat, Juliette, Candéias, Serge M., Stefan, Dinu, Saintigny, Yannick, Chevalier, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321381/ https://www.ncbi.nlm.nih.gov/pubmed/30487462 http://dx.doi.org/10.3390/ijms19123793 |
Ejemplares similares
-
Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation
por: Lesueur, Paul, et al.
Publicado: (2018) -
Sensitization of chondrosarcoma cells with PARP inhibitor and high-LET radiation
por: Césaire, Mathieu, et al.
Publicado: (2019) -
Beyond lymphopenia, unraveling radiation-induced leucocyte subpopulation kinetics and mechanisms through modeling approaches
por: Pham, Thao-Nguyen, et al.
Publicado: (2023) -
Hadrontherapy Interactions in Molecular and Cellular Biology
por: Thariat, Juliette, et al.
Publicado: (2019) -
Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
por: Vikas, Praveen, et al.
Publicado: (2020)